StockStory flags select buys and sells

Recent StockStory research, published across Yahoo and Yahoo Finance on April 3, 2026, outlines several stocks it views as attractive or challenged. The firm focuses on profitability, growth trends and valuation, and distinguishes between companies it believes can capitalize on their margins and those that may struggle despite being in the black.

Two companion sets of reports address profitable companies across sectors and business services stocks that have recently hit 52‑week lows, framing them either as potential rebound candidates or as names to avoid.

In healthcare, StockStory flags GE HealthCare as a stock to sell despite a trailing 12‑month GAAP operating margin of 13.4%. The company’s annual revenue growth of 2.7% over the last two years is described as lagging other healthcare companies, and its organic revenue has disappointed over the same period. The report adds that this may leave GE HealthCare reliant on acquisitions to stimulate growth. The shares are cited at $70.42, trading at 14.2x forward price-to-earnings.

Northern Trust is also listed as a stock to turn down. The financial services group has a trailing 12‑month GAAP operating margin of 28.6%, but its 5.8% annual revenue growth over the past five years is characterized as muted versus peers. Earnings per share increased 9.3% annually over that period, which StockStory says fell short of its peer group average. The stock is reported at $142.24 per share, or 13x forward P/E.

In a separate consumer and technology-focused note, Cushman & Wakefield is cited as a stock to sell. The commercial real estate services provider has a trailing 12‑month GAAP operating margin of 4.4%, and its 5.6% annual revenue growth over the last five years is said to trail other consumer discretionary companies. Forecast free cash flow margins are described as pointing to weak cash conversion over the next year, and returns on capital are characterized as eroding from a low base. Cushman & Wakefield’s shares are quoted at $12.51, at 8.7x forward P/E.

Penumbra, a medical device maker with a trailing 12‑month GAAP operating margin of 13.5%, is another stock StockStory suggests investors brush off. The firm notes Penumbra’s revenue base of $1.40 billion as evidence of subscale operations, implying fewer distribution channels than larger rivals. It also cites low returns on capital as a sign that capital allocation has been ineffective. Penumbra’s stock price is given as $330.34, corresponding to 65.1x forward P/E.

Against these more cautious views, StockStory identifies Shopify (SHOP) as a profitable company it believes can use its financial strength to compete effectively. The e-commerce platform provider posts a trailing 12‑month GAAP operating margin of 12.7%. The report characterizes Shopify as enabling merchants of all sizes to build and manage their businesses across multiple sales channels, and presents it as a stock expected to outperform.

Doximity is similarly labeled a stock to watch. The digital healthcare platform reports a trailing 12‑month GAAP operating margin of 37.4%. StockStory notes that more than 80% of U.S. physicians are members of its digital community, using the platform to collaborate, follow medical news, manage their careers and conduct virtual patient visits. The research frames Doximity as a business that leverages profitability and a strong user base.

Another April 3 report focuses on business services stocks that have recently touched 52‑week lows. Within this group, StockStory flags CDW and Rumble as stocks to sell, while recommending investors watch Genpact.

CDW, a multi-brand IT solutions provider, is described as facing growth constraints from its scale. StockStory points to below-average annual revenue growth of 2.4% over the last two years and forecasts sales growth of 2.8% for the next year, which it says suggests shaky demand. Earnings per share have been flat over the last two years and are said to have underperformed the sector average. CDW’s shares are reported at $122.02, implying a forward P/E of 11.5x.

Rumble, a video sharing platform positioned as a free speech alternative to mainstream services, is also seen as risky. Over the last five years, expenses as a percentage of revenue have increased and operating margin has declined by 31.9 percentage points. StockStory cites a history of cash burn and a weakening margin profile, and notes that negative EBITDA both limits access to capital and raises the risk of shareholder dilution if conditions worsen. Rumble’s stock price is stated as $4.96, at 19.7x forward enterprise value-to-EBITDA.

Genpact, a professional services firm specializing in digital transformation, AI and data analytics, is the oversold stock StockStory labels one to watch. The note highlights its one-month return of -6.4% and its roots in a 2005 spin-off from General Electric, but does not provide specific valuation metrics. Instead, it presents Genpact as a company helping clients modernize operations through technology-driven solutions.